Gait Analysis During Level and Uphill Walking After Lengthening Osteotomy of the Lateral Column (CALCOT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03487497 |
|
Recruitment Status :
Completed
First Posted : April 4, 2018
Last Update Posted : March 2, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
A common surgical treatment for posterior tibial tendon dysfunction (and the resulting flat foot) is the correction through a calcaneal lengthening osteotomy of the lateral column (LLC). Clinical studies showed pain relief and functional improvements through different scores. However, according to clinical experience, some patients complain about a limited ankle dorsiflexion after LLC surgery. Several joints of the foot (talocrural, subtalar, talonavicular, calcaneocuboid) contribute to the overall range of motion in foot plantarflexion/dorsiflexion and pronation/supination. Changes in the range of motion in one joint can affect all the other joints. For instance, it was shown that a fusion of the talonavicular joint removes most of the residual hindfoot motion in plantarflexion/dorsiflexion and pronation/supination. Because the lengthening of the lateral column presumably decreases the mobility of the medial column and thus of the talonavicular joint, this surgery can influence the range of motion of the other joints, and hence contribute to the reported decreased ankle dorsiflexion motion.
Patients after LLC have less plantarflexion of the first metatarsal throughout stance of level walking and less inversion of the hindfoot during push-off compared to healthy subjects. Uphill walking requires more ankle plantarflexion and dorsiflexion than level walking. A limitation of the ankle joint mobility especially in dorsiflexion could therefore lead to additional or greater changes in gait patterns (hindfoot and forefoot kinematics) during uphill walking.
The primary objective is:
• To compare differences in hindfoot and forefoot kinematics between level and uphill treadmill walking in relation to passive range of motion
The secondary objectives are:
- To compare lower leg muscle activation during level and uphill treadmill walking between patients after LLC and healthy subjects
- To test the association between muscle strength, muscle activation patterns and hindfoot and forefoot kinematics during level and uphill walking and heel rise
- To relate clinical outcome of LLC surgery by functional scores to passive range of motion
| Condition or disease | Intervention/treatment |
|---|---|
| Osteotomy Lengthening; Leg | Procedure: Lateral column lengthening osteotomy |
| Study Type : | Observational |
| Actual Enrollment : | 32 participants |
| Observational Model: | Cohort |
| Time Perspective: | Retrospective |
| Official Title: | Gait Analysis During Level and Uphill Walking After Lengthening Osteotomy of the Lateral Column |
| Actual Study Start Date : | November 20, 2017 |
| Actual Primary Completion Date : | December 31, 2018 |
| Actual Study Completion Date : | December 31, 2018 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Patients
Patients who underwent lateral column lengthening osteotomy
|
Procedure: Lateral column lengthening osteotomy
Lengthening osteotomy of the lateral column of the foot |
|
Healthy subjects
Healthy subjects without intervention
|
- Passive plantarflexion and dorsiflexion range of motion [ Time Frame: 0 months ]measured using a Biodex
- 3D hindfoot and forefoot range of motion during level and uphill walking [ Time Frame: 0 months ]assessed as max plantarflexion to max dorsiflexion of the ankle using marker and camera based motion capture
- Isokinetic strength in plantarflexion, dorsiflexion, inversion, and eversion [ Time Frame: 0 months ]Max moment assessed using a Biodex
- Lower leg muscle activation [ Time Frame: 0 months ]Max electromyographic signal intensity
- Clinical outcome [ Time Frame: 0 months ]assessed by American Orthopaedic Foot and Ankle Society (AOFAS) Hindfoot Score (questionnaires) (best score: 100 - no limitations)
- Functional outcome [ Time Frame: 0 months ]assessed by Foot Function Index (questionnaire) (best score: 0; worst score 100)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- age > 18 years
- age < 70 years
- Patients:
- Unilateral surgery for posterior tibial tendon dysfunction by flexor digitorum longus transfer and lateral lengthening osteotomy of the calcaneus
- Minimum of 2 years postoperatively
Exclusion Criteria:
- Neuromuscular disorders affecting gait
- Cardiovascular disease
- Diabetes
- Pregnancy (if unknown, a pregnancy test (urine test) will be performed)
- Body mass index > 35 kg/m2
- Patients:
- Additional pathologies that influence the mobility of the ankle joint
- Bilateral surgery
- Use of walking aids
- Healthy control group:
- Lower extremity surgery
- Pain in the lower extremities within the last 6 months
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03487497
| Switzerland | |
| University Hospital Basel | |
| Basel, Basel Stadt, Switzerland, 4031 | |
| Principal Investigator: | Corina Nüesch, PhD | University Hospital, Basel, Switzerland |
| Responsible Party: | University Hospital, Basel, Switzerland |
| ClinicalTrials.gov Identifier: | NCT03487497 |
| Other Study ID Numbers: |
2015-00254 |
| First Posted: | April 4, 2018 Key Record Dates |
| Last Update Posted: | March 2, 2020 |
| Last Verified: | February 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
gait analysis electromyography strength test walking |

